Literature DB >> 31930023

Ophiopogon japonicus inhibits radiation-induced pulmonary inflammation in mice.

Qi-Wei Yao1,2, Xiao-Ying Wang3, Jian-Cheng Li1,2, Jun Zhang4.   

Abstract

BACKGROUND: Radiation-induced lung injury, including the acute pulmonary inflammation and chronic pulmonary fibrosis remains the major complication of thoracic radiotherapy.
METHODS: In this study, we assessed the effects of Ophiopogon japonicus (O. japonicas) in inhibiting the radiation-induced pulmonary inflammation through an acute lung injury mouse model using C57BL/6 mice that received 18 Gy irradiation to the thoracic region. Starting at 4 days before radiation, mice were treated with O. japonicus or dexamethasone combined with cephalexin or vehicle daily for 14 days.
RESULTS: Exposure to radiation resulted in pulmonary inflammation in mice, but treatment with O. japonicus or dexamethasone-cephalexin could both significantly reduce radiation-induced pulmonary inflammation through inhibition of IL-6, TNF-α, TGF-β1, hydroxyproline, MDA, MMP-2 and TIMP-2 in plasma or lung tissue. In addition, through analyzing tissue damage, cytokines and inflammation-related protein at 12 weeks after irradiation, we found that the protective effect of O. japonicus was more enduring than dexamethasone-cephalexin.
CONCLUSIONS: As radiation-induced lung injury is a major obstacle in thoracic radiotherapies and seriously affect the quality of patients' life. Application of O. japonicus may be a novel strategy to manage radiation-induced pulmonary inflammation. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Ophiopogon japonicus (O. japonicas); pulmonary inflammation; radiotherapy

Year:  2019        PMID: 31930023      PMCID: PMC6944568          DOI: 10.21037/atm.2019.11.01

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  21 in total

Review 1.  Effect of transforming growth factor-β1 869C/T polymorphism and radiation pneumonitis.

Authors:  Yingtian Wang; Xingguang Wang; Xiyan Wang; Deyong Zhang; Shujuan Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.

Authors:  Liguang Chen; David M Brizel; Zahid N Rabbani; Thaddeus V Samulski; Catherine L Farrell; Nicole Larrier; Mitchell S Anscher; Zeljko Vujaskovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

3.  Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice.

Authors:  Alexandra Paun; Jessica Fox; Viviane Balloy; Michel Chignard; Salman T Qureshi; Christina K Haston
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-15       Impact factor: 7.038

Review 4.  Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.

Authors:  David A Palma; Suresh Senan; Kayoko Tsujino; Robert B Barriger; Ramesh Rengan; Marta Moreno; Jeffrey D Bradley; Tae Hyun Kim; Sara Ramella; Lawrence B Marks; Luigi De Petris; Larry Stitt; George Rodrigues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-09       Impact factor: 7.038

5.  Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells.

Authors:  Meijuan Chen; Yuanyuan Guo; Ruolin Zhao; Xiaoxia Wang; Miao Jiang; Haian Fu; Xu Zhang
Journal:  Int J Oncol       Date:  2016-05-10       Impact factor: 5.650

6.  Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.

Authors:  M S Anscher; F M Kong; L B Marks; G C Bentel; R L Jirtle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-15       Impact factor: 7.038

7.  All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis.

Authors:  Chiharu Tabata; Yoshio Kadokawa; Rie Tabata; Meiko Takahashi; Kae Okoshi; Yoshiharu Sakai; Michiaki Mishima; Hajime Kubo
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

8.  Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation.

Authors:  M S Anscher; L B Marks; T D Shafman; R Clough; H Huang; A Tisch; M Munley; J E Herndon; J Garst; J Crawford; R L Jirtle
Journal:  J Clin Oncol       Date:  2001-09-01       Impact factor: 44.544

Review 9.  Ophiopogon japonicus--A phytochemical, ethnomedicinal and pharmacological review.

Authors:  Min-Hui Chen; Xiao-Jia Chen; Mei Wang; Li-Gen Lin; Yi-Tao Wang
Journal:  J Ethnopharmacol       Date:  2016-01-27       Impact factor: 4.360

10.  Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Francesca Polverino; Maria E Laucho-Contreras; Yuanyuan Shi; Yushi Liu; Juan C Osorio; Yohannes Tesfaigzi; Victor Pinto-Plata; Bernadette R Gochuico; Ivan O Rosas; Caroline A Owen
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  4 in total

1.  Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease.

Authors:  Bo Liang; Xiao-Xiao Zhang; Ning Gu
Journal:  BMC Complement Med Ther       Date:  2020-11-13

2.  Erratum to ophiopogon japonicus inhibits radiation-induced pulmonary inflammation in mice.

Authors: 
Journal:  Ann Transl Med       Date:  2022-03

3.  The Effect of Ophiopogonin C in Ameliorating Radiation-Induced Pulmonary Fibrosis in C57BL/6 Mice: An Update Study.

Authors:  Xiaobin Fu; Tingting Li; Qiwei Yao
Journal:  Front Oncol       Date:  2022-03-30       Impact factor: 6.244

4.  Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway.

Authors:  Xiu Yu; Dandan Chen; Lingwei Wang; Jie Li; Khalid Khan; Haihui Chen; Yutian Liang; Huanmin Luo; Chen Qiu
Journal:  Ann Transl Med       Date:  2020-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.